🇺🇸 FDA

Company profile · Sponsor

Organon

Organon Pharma Pty Ltd

E8AB73E · TGA pharma AU
Pipeline
1
Drugs
6
Patents
0

Quick answer

Organon (E8AB73E) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 1 pipeline program, 6 drugs, and 0 patents to this profile..

Company facts

Ticker E8AB73E
Exchange TGA
Company type pharma
Headquarters AU

Pipeline (1)

Search pipeline →

  1. E6005

    Organon

    Atopic Dermatitis

    phase 2 small molecule completed

    1 trial

Drugs (6)

Search drugs →

  1. asenapine

    SAPHRIS

    TRANSDERMAL approved

    N05AH05

  2. betamethasone acetate + betamethasone sodium phosphate

    CELESTONE CHRONODOSE

  3. corifollitropin alfa

    ELONVA

    G03GA09

  4. etonogestrel

    IMPLANON NXT

    IMPLANTATION approved

  5. etonogestrel + ethinylestradiol

    NUVARING

  6. follitropin beta

    PUREGON 300 IU/0.36 ML

    G03GA06

Frequently asked questions

What is Organon?

Organon (E8AB73E) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 1 pipeline program, 6 drugs, and 0 patents to this profile..

What pipeline programs does Organon sponsor?

We track 1 ClinicalTrials.gov-linked program for Organon, including E6005. Open each program for phase, modality, NCT IDs, and indication details.

Where does Organon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.